Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orforglipron

ATTAIN-J

Eli Lilly · Phase 3 · Completed · Enrollment 238

NCT05931380

ArmPopulationDoseWeeksEstimandWeight change
Placebo QDObesity or overweightn/r72n/rn/r
6 mg Orforglipron QDObesity or overweight6 mg72n/rn/r
12 mg Orforglipron QDObesity or overweight12 mg72n/rn/r
36 mg Orforglipron QDObesity or overweight36 mg72n/rn/r